Information Provided By:
Fly News Breaks for April 2, 2018
JNJ, SYK
Apr 2, 2018 | 16:18 EDT
Evercore ISI analyst Vijay Kumar started Stryker (SYK) with an In Line rating and $165 price target, noting that the company has been a net share gainer in most orthopedics end markets, while Johnson & Johnson (JNJ) has been a net share loser across the board.